The decision was taken late on Monday evening after the Hyderabad-based Bharat Biotech became the third pharmaceutical firm to apply to the Drugs Controller General of India (DCGI) for emergency use authorisation for its indigenously developed Covid-19 vaccine Covaxin.
source https://www.hindustantimes.com/india-news/review-of-covid-vaccine-applications-of-pfizer-sii-bharat-biotech-tomorrow-report/story-PjfowCTwrCLheo8A5724zO.html
No comments:
Post a Comment